Nephros (NEPH) Change in Account Payables (2014 - 2026)
Nephros (NEPH) recorded quarterly Change in Account Payables of $562000.0 in Q1 2026, up 2037.93% quarter-over-quarter from -$29000.0 in Q4 2025, and up 635.24% on a YoY basis from $76437.8 in Q1 2025.
Nephros (NEPH) Change in Account Payables (2014 - 2026) Analysis & Trends
Nephros' Change in Account Payables history runs 13 years deep, the most recent figure standing at $562000.0 for Q1 2026.
- In Q1 2026, Change in Account Payables rose 635.24% year-over-year to $562000.0; the TTM figure through Mar 2026 stood at $926000.0 (up 262.74% YoY), while the FY2025 annual figure was $259000.0, up 217.73% from the prior year.
- Change in Account Payables was $562000.0 for Q1 2026 at Nephros, up from -$29000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $562000.0 in Q1 2026 to a low of -$766000.0 in Q3 2024.
- Historically, Change in Account Payables has averaged $8294.1 across 5 years, with a median of $45000.0 in 2024.
- The sharpest annual moves came in 2022 and 2024: Change in Account Payables tumbled 675.0% in 2022, then surged 1261.9% in 2024.
- A 5-year view of Change in Account Payables shows it stood at -$38000.0 in 2022, then soared by 278.95% to $68000.0 in 2023, then soared by 277.94% to $257000.0 in 2024, then tumbled by 111.28% to -$29000.0 in 2025, then jumped by 2037.93% to $562000.0 in 2026.
- The last three Change in Account Payables figures came in at $562000.0 (Q1 2026), -$29000.0 (Q4 2025), and $312000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 73.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 6.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 23.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 4.93 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 102.00 Mn |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn | 562,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 562,000.00 |
| Mar 31, 2026 | 562,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Sep 30, 2025 | 312,000.00 |
| Sep 30, 2025 | 312,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Mar 31, 2025 | -105,000.00 |
| Mar 31, 2025 | -105,000.00 |
| Dec 31, 2024 | 257,000.00 |
| Dec 31, 2024 | 257,000.00 |
| Sep 30, 2024 | -766,000.00 |
| Sep 30, 2024 | -766,000.00 |
| Jun 30, 2024 | 45,000.00 |
| Jun 30, 2024 | 45,000.00 |
| Mar 31, 2024 | 244,000.00 |
| Mar 31, 2024 | 244,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Dec 31, 2023 | 68,000.00 |